99 related articles for article (PubMed ID: 16304244)
1. Therapeutic intervention: assessing the role of the international consensus guidelines.
Nathan SD
Chest; 2005 Nov; 128(5 Suppl 1):533S-539S. PubMed ID: 16304244
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory agents for idiopathic pulmonary fibrosis.
Davies HR; Richeldi L; Walters EH
Cochrane Database Syst Rev; 2003; (3):CD003134. PubMed ID: 12917947
[TBL] [Abstract][Full Text] [Related]
3. Assessment of current practice in the diagnosis and therapy of idiopathic pulmonary fibrosis.
Peikert T; Daniels CE; Beebe TJ; Meyer KC; Ryu JH;
Respir Med; 2008 Sep; 102(9):1342-8. PubMed ID: 18621518
[TBL] [Abstract][Full Text] [Related]
4. Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Walter N; Collard HR; King TE
Proc Am Thorac Soc; 2006 Jun; 3(4):330-8. PubMed ID: 16738197
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary fibrosis--a therapeutic dilemma?].
Günther A; Markart P; Eickelberg O; Seeger W
Med Klin (Munich); 2006 Apr; 101(4):308-12. PubMed ID: 16607487
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of idiopathic pulmonary fibrosis].
Dury S
Rev Mal Respir; 2006 Apr; 23(2 Pt 2):5S87-5S91. PubMed ID: 16788517
[No Abstract] [Full Text] [Related]
7. Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach.
Nathan SD
Clin Chest Med; 2006 Mar; 27(1 Suppl 1):S27-35, vi. PubMed ID: 16545630
[TBL] [Abstract][Full Text] [Related]
8. Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens.
Fiorucci E; Lucantoni G; Paone G; Zotti M; Li BE; Serpilli M; Regimenti P; Cammarella I; Puglisi G; Schmid G
Eur Rev Med Pharmacol Sci; 2008; 12(2):105-11. PubMed ID: 18575160
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of pulmonary fibrosis].
Cottin V
Presse Med; 2002 Oct; 31(34):1613-23. PubMed ID: 12426980
[TBL] [Abstract][Full Text] [Related]
10. Therapies for interstitial lung disease: past, present and future.
Kim R; Meyer KC
Ther Adv Respir Dis; 2008 Oct; 2(5):319-38. PubMed ID: 19124380
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide in scleroderma lung disease.
Kuschner WG
N Engl J Med; 2006 Sep; 355(11):1173; author reply 1174. PubMed ID: 16971726
[No Abstract] [Full Text] [Related]
12. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
Franzolini N; Quartuccio L; De Marchi G; De Vita S
Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic interstitial pneumonias: a re-appraisal of idiopathic pulmonary fibrosis.
Taylor DA; du Bois RM
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1086-98. PubMed ID: 11769766
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic pulmonary fibrosis; description of a Dutch cohort].
Barlo NP; van Moorsel CH; van den Bosch JM; van de Graaf EA; Kwakkel-van Erp JM; Grutters JC
Ned Tijdschr Geneeskd; 2009; 153():B425. PubMed ID: 19785823
[TBL] [Abstract][Full Text] [Related]
15. Advances in immunosuppressive therapy.
Marder W; McCune WJ
Semin Respir Crit Care Med; 2007 Aug; 28(4):398-417. PubMed ID: 17764058
[TBL] [Abstract][Full Text] [Related]
16. [Idiopathic pulmonary fibrosis. III. Case report].
Lode H; Erbes R
Dtsch Med Wochenschr; 2001 Apr; 126(14):401. PubMed ID: 11354052
[No Abstract] [Full Text] [Related]
17. Therapeutic options for systemic sclerosis related interstitial lung diseases.
Mouthon L; Bérezné A; Guillevin L; Valeyre D
Respir Med; 2010 Jul; 104 Suppl 1():S59-69. PubMed ID: 20630349
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive therapy for autoimmune lung diseases.
Meyer KC; Bierach J
Immunol Allergy Clin North Am; 2012 Nov; 32(4):633-69. PubMed ID: 23102070
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
Kondoh Y; Taniguchi H; Yokoi T; Nishiyama O; Ohishi T; Kato T; Suzuki K; Suzuki R
Eur Respir J; 2005 Mar; 25(3):528-33. PubMed ID: 15738299
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic pulmonary fibrosis: current and future treatment options.
Davies HR; Richeldi L
Am J Respir Med; 2002; 1(3):211-24. PubMed ID: 14720059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
